[ORGANIZATION]
Boehringer Ingelheim
Featured in 15 tracked stories · first seen
Situations
CKD screening initiative in Extremadura
2 clusters · 3 sources · last updated
Latest: Extremadura launches mobile kidney disease screening in rural areas
The RADAR project has introduced a mobile health unit to provide free chronic kidney disease (CKD) screening across rural areas in Extremadura, Spain. Led by the Servicio Extremeño de Salud (SES) and FundeSalud, the init
UK and Ireland Bluetongue virus outbreak 2026
18 clusters · 36 sources · last updated
Latest: Bluetongue virus spreads through livestock in Ireland and Great Britain
By late September 2026, the Bluetongue virus (BTV-3) outbreak has expanded significantly across the British Isles. In addition to the ongoing situation in the United Kingdom, the virus has been confirmed in Ireland. The
AI-driven drug discovery and oncology advances
13 clusters · 37 sources · last updated
Latest: AI accelerates drug discovery and cancer care with 200+ drugs in clinical trials
By late September 2026, the transition of AI-driven drug discovery from theory to clinical application has accelerated significantly. Global development now includes over 200 AI-original drugs in various clinical stages.
Rural mental health access challenges
2 clusters · 9 sources · last updated
Latest: Rural Minds launches national mental health program for youth
Reports indicate significant mental health challenges in rural America, driven by geographic isolation and a shortage of healthcare providers. Data from Crisis Text Line shows that between 2019 and 2024, many rural resid
Also covered in
-
Boehringer Ingelheim launches cardiovascular risk awareness initiative
[HEALTH] · 2 sources ·
-
Boehringer Ingelheim completes new factory wing in Koropi
[BUSINESS] · 4 sources ·
-
Global business updates: AI funding, biotech deals, and real estate conversions
[BUSINESS] · 2 sources ·
-
CIBER funds Crohn's disease lifestyle intervention study
[HEALTH] · 4 sources ·
-
China International Import Expo enters final preparations for 9th edition
[BUSINESS] · 2 sources ·
-
Boehringer Ingelheim expands portfolio via new IPF therapy and Evax AG acquisition
[BUSINESS] · 2 sources ·
-
Boehringer Ingelheim reports Phase III success for obesity drug survodutida
[HEALTH] · 5 sources ·